An expert panel of India’s drug regulator on Friday sought additional data from drugmaker Dr.Reddy’s Laboratories on its Sputnik V COVID-19 vaccine trial, in its second such request after an initial evaluation in February. The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both …
Read More »
Asian Tribune Your Multilingual Newspaper covering World and local news News